Time of Oxytocin Initiation at 2nd Stage of Labor and Adverse Outcomes
Association Between Time of Oxytocin Initiation at 2nd Stage of Labor and Adverse Outcomes
1 other identifier
interventional
120
1 country
1
Brief Summary
Early oxytocin administration at the 2nd stage of labor is associated with a higher rate of vaginal delivery, shorter second stage duration, and fewer adverse maternal and neonatal outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 10, 2023
CompletedStudy Start
First participant enrolled
October 1, 2023
CompletedFirst Posted
Study publicly available on registry
December 26, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
ExpectedDecember 26, 2023
December 1, 2023
2 years
September 10, 2023
December 22, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Mode of delivery
Vaginal or instrumental or cesarean
Delivery
Secondary Outcomes (8)
2nd stage duration
Delivery
intrapartum fever
Delivery or 48 hours postpartum
Meconium stain
Delivery
Postpartum hemorrhage
Delivery
FHR decelerations
Delivery
- +3 more secondary outcomes
Study Arms (2)
Immediate oxytocin
EXPERIMENTALThis arm will receive oxytocin when entering 2nd stage (full dilation)
Delayed oxytocin
OTHERThis arm will receive oxytocin one hour after entering 2nd stage (full dilation)
Interventions
Eligibility Criteria
You may qualify if:
- Singleton pregnancy
- Maternal age ≥ 18 years' old
- Oxytocin administration initiated or renewed during second stage of labor
You may not qualify if:
- Maternal age \< 18 years' old
- Multiple gestation pregnancy
- Known fetal malformations
- Uterine scar
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rambam medical health campus
Haifa, 31999, Israel
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor of OBGYN
Study Record Dates
First Submitted
September 10, 2023
First Posted
December 26, 2023
Study Start
October 1, 2023
Primary Completion
October 1, 2025
Study Completion (Estimated)
October 1, 2026
Last Updated
December 26, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will share